About Delaware Crossing Investor Group
Delaware Crossing Investor Group, established in 2005, is an angel investment group based in Warrington Township, United States. It primarily focuses on Seed investments in companies in United States. Its portfolio includes 11 firms, spanning the Enterprise Applications, FinTech sectors. Its most notable investments include companies like Thubrikar Aortic Valve, Novira Therapeutics and Hulafrog. As of Oct 2026, Delaware Crossing Investor Group has witnessed 4 portfolio exits. Its latest investment was a Undisclosed Seed round in Vytala on Sep 19, 2024, which also saw participation from Robin Hood Ventures and Ulu Ventures.
To date, 21 investors have co-invested in Delaware Crossing Investor Group's portfolio companies, including prominent names like Robin Hood Ventures.
Key Metrics
Founded Year
2005
Location
Warrington Township, United States
Portfolio Companies
Sectors of Investment
Stages of Investment
Seed & Series A
Locations of Investment
Delaware Crossing Investor Group's List of Top Investments
Delaware Crossing Investor Group has a portfolio of 11 companies. Their most notable investmentis in Life.ioTheir portfolio spans across and United States. They have invested in Enterprise Applications, FinTech, Consumer and 9 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by Delaware Crossing Investor Group:Innovating durable transcatheter aortic valve technology for improved patient outcomes. This company focuses on developing and researching advanced heart valve replacement solutions. Their core offering, the Optimum TAV system, is designed to enhance valve durability and improve the lives of patients with aortic valve disease. They are involved in clinical research and development, presenting their findings at major medical conferences. The company is dedicated to advancing the field of transcatheter aortic valve implantation (TAVI) through technological innovation. Their investigational devices are currently undergoing clinical trials to demonstrate safety and efficacy. They are committed to providing cutting-edge solutions for aortic valve replacement.
Key facts about Thubrikar Aortic Valve
- Founded Year: 2010
- Location: Philadelphia (United States)
- Stage: Series A
- Total Funding till date: $4.22M
- Employee Count: 5 as on Aug 31, 2026
- Investors: Heartland Angels, Delaware Crossing Investor Group and 3 Others
- Latest Funding Round: Series A, Jul 16, 2018, $*****
Developer of antiviral therapeutics for the treatment of chronic HBV infections. The company's oral drugs target the capsid of the virus and offer a promising treatment option both as monotherapy and in combination with current standards of care.
Key facts about Novira Therapeutics
- Founded Year: 2009
- Location: Radnor (United States)
- Stage: Acqui-Hired
- Total Funding till date: $65M
- Employee Count: 1 as on Sep 30, 2026
- Investors: Versant Ventures, Canaan and 8 Others
- Latest Funding Round: Series A, Dec 22, 2014, $*****
- Highlight: Editors' Pick
3. Hulafrog
Hulafrog, Inc. is a network of hyperlocal sites that help moms find things to do with their kids, including local events, class providers, birthday parties. It is part daily event calendar, part parent-rated business directory available via the web, mobile, and email. With a daily "Our Pick" email and family-friendly deals, Hulafrog acts as a guide to parents with kids in suburban areas.
Key facts about Hulafrog
- Founded Year: 2010
- Location: Atlantic Highlands (United States)
- Stage: Acquired
- Total Funding till date: $650K
- Employee Count: 33 as on Sep 30, 2026
- Investors: Raptor Group, New York Angels and 3 Others
- Latest Funding Round: Seed, Jul 09, 2014, $*****
- Highlight: Acquired
4. Life.io
Life.io is a reward-based platform for monitoring and improving health at an individual level. The platform helps in capturing insights on health and other lifestyle behaviors and help customers connect to the products and services that best suit their needs. It provides a "LifeStyle Score" which brings together biometric, lifestyle and behavioral parameters to provide feedback on a user's daily habits. It also features a community for support.
Key facts about Life.io
- Founded Year: 2012
- Location: Philadelphia (United States)
- Stage: Acqui-Hired
- Total Funding till date: $2.41M
- Employee Count: 2 as on Aug 31, 2026
- Investors: Tigerlabs, Eldridge Industries and 7 Others
- Latest Funding Round: Seed, Aug 16, 2016, $*****
- Highlight: Editors' Pick

5. Measure
Platform offering social media analytics software. The platform enables members to get insights into social media posts and make strategies. It allows members to connect all social media accounts in one place, understand the performance range, and identify what type of content increases engagement and followers. It also helps to make reports to analyze and compare performance.
Key facts about Measure
- Founded Year: 2019
- Location: Chalfont (United States)
- Stage: Seed
- Total Funding till date: $1.33M
- Employee Count: 12 as on Aug 31, 2026
- Investors: Higher Ground Labs, Robin Hood Ventures and 4 Others
- Latest Funding Round: Seed, Apr 14, 2025, $*****
Delaware Crossing Investor Group's Year-on-Year Investment Trends
Delaware Crossing Investor Group has invested in 11 companies over the last 18 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in Vytala.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 0 | 0 |
2024 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
2022 | 0 | 0 | 0 |
2021 | 1 | 0 | 1 |
2020 | 0 | 0 | 0 |
2019 | 0 | 0 | 0 |
2018 | 1 | 0 | 1 |
Delaware Crossing Investor Group's Investments by Stage
Delaware Crossing Investor Group has made 8 investments in Seed stage with an average round size of $1.06M and 3 investments in Series A stage with an average round size of $2.48M.Stage of entry | No. of Investments |
|---|---|
Seed | 8 |
Series A | 3 |
Note: We have considered here, only first round of investments
Delaware Crossing Investor Group's Investments by Sector
Delaware Crossing Investor Group has a diverse portfolio, with companies operating in the Enterprise Applications, Life Sciences, Consumer, EdTech and FinTech. Notably, it has invested in 10 Tech companies, 7 Enterprise (B2B) companies, 3 Consumer (B2C) companies and at least 3 companies focusing on Software.Sector | No. of Investments |
|---|---|
Enterprise Applications | 4 |
Life Sciences | 4 |
Consumer | 3 |
EdTech | 2 |
FinTech | 2 |
Others | 12 |
Note: We have considered here, only first round of investments
Delaware Crossing Investor Group's Investments by Geography
Delaware Crossing Investor Group has made most investments in United States (11).Delaware Crossing Investor Group's recent investments
Delaware Crossing Investor Group has not made any investment in 2026 so far.Here are the most recent investments by Delaware Crossing Investor Group:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 19, 2024 | United States | Seed | 9628 | [+3] | |
Apr 21, 2023 | United States | Seed | 5029 | [+4] | |
Aug 25, 2021 | United States | Series A | 2053 | [+4] | |
Feb 13, 2018 | United States | Seed | 7604 | ||
Jan 06, 2016 | United States | Seed | 7118 | [+2] |
Acquired companies in Delaware Crossing Investor Group's Portfolio
4 companies from Delaware Crossing Investor Group's portfolio have been acquired. The most recent acquisition was Hulafrog in Jan 2023 by CertifiKID for $*****.Here are Delaware Crossing Investor Group's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 10, 2023 | Jun 04, 2013 | Seed | 5925 | |
May 21, 2019 | Jan 06, 2016 | Seed | 6757 | |
Nov 04, 2015 | Jul 26, 2011 | Seed | 2936 | |
Nov 09, 2012 | Mar 15, 2011 | Series A | 2768 |
Co-investors of Delaware Crossing Investor Group
Over the past 18 years, 36 investors have co-invested in Delaware Crossing Investor Group's portfolio companies. This includes funds and angels.
- Invested before Delaware Crossing Investor Group: BioAdvance, HHS and 5 others have invested in rounds before Delaware Crossing Investor Group. There is 1 company where BioAdvance has invested before Delaware Crossing Investor Group and 1 company where HHS has invested before Delaware Crossing Investor Group.
- Top Co-investors of Delaware Crossing Investor Group: 21 investors entered a company along with Delaware Crossing Investor Group. These include investors like Robin Hood Ventures (7 companies).
- Invested after Delaware Crossing Investor Group: A total of 8 investors have invested in Delaware Crossing Investor Group's portfolio after their investments. Top Investors include Labcor (1 company) and Versant Ventures (1 company).
Recent News related to Delaware Crossing Investor Group
•
Vytala Inc Debuts With Initial Close of Pre-Seed Financing to End Nutrient Deficiencies in Patients With Digestive Disordersintelligence360•Oct 14, 2024•Robin Hood Ventures, Vytala, Jumpstart, Ulu Ventures and 2 others
•
Vytala Inc Debuts With Initial Close of Pre-Seed Financing to End Nutrient Deficiencies in Patients With Digestive DisordersBusiness Wire•Sep 19, 2024•Vytala, Robin Hood Ventures, The MBA Fund, Delaware Crossing Investor Group and 2 others
•
Measure Studio Raises Seed Funding to Fuel Continued Innovation in AI-Powered Content IntelligenceACCESSWIRE•Apr 21, 2023•Measure, Bombas, Pinterest, CrowdTangle and 7 others
•
Vesteck, Inc. Continues to Add Investors, Bio Advance and Angel Star Ventures Increase Series a Investment to >$5.2 MPR Newswire•Sep 16, 2021•VESTECK, BioAdvance, Angel Star Ventures, New World Angels and 5 others
•
Noble Midstream and Salt Creek Midstream’s Delaware Basin Joint VentureGlobal Legal Chronicle•Mar 06, 2019•Noble Energy, Delaware Crossing Investor Group
•
Delaware chemical startup amid $1M seed roundThe Business Journals•Feb 21, 2018•Robin Hood Ventures, ThruPore Technologies, Delaware Crossing Investor Group
•
The Business Journals•Novira Therapeutics, Robin Hood Ventures, Delaware Crossing Investor Group, Mid Atlantic Angel Group